A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

NCT06773208 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: Azacitidine (AZC)
DRUG: Venetoclax

Sponsor

Memorial Sloan Kettering Cancer Center